Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Credit agrmnt [a] Appointed director Quarterly results CC transcript
|
ENDOLOGIX INC (ELGX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/28/2018 |
GN
| New Research Coverage Highlights MACOM Technology Solutions, Arrowhead Pharmaceuticals, PTC Therapeutics, Boot Barn, Darling Ingredients, and Endologix — Consolidated Revenues, Company Growth, and Expectations for 2018 |
06/28/2018 |
GN
| Market Trends Toward New Normal in Endologix, Sanmina, First American Financial, Expeditors International of Washington, Liberty Broadband, and Nu Skin Enterprises — Emerging Consolidated Expectations, Analyst Ratings |
02/12/2018 |
GN
| Detailed Research: Economic Perspectives on Haemonetics, Endologix, NRG Yield, Cirrus Logic, Macquarie Infrastructure, and Shake Shack — What Drives Growth in Today's Competitive Landscape |
12/19/2017 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within Endologix, Haemonetics, Prudential Financial, AdvanSix, PolyOne, and Rexford Industrial Realty — New Research Emphasizes Economic Growth |
03/03/2017 |
GN
| EGLX UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Endologix, Inc. and a Lead Plaintiff Deadline of March 6, 2017 |
02/24/2017 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Endologix, Inc. and Certain Officers – ELGX |
02/22/2017 |
GN
| Endologix Reports Results for the Fourth Quarter and Full Year 2016 |
02/15/2017 |
GN
| ENDOLOGIX LOSS NOTICE: Rosen Law Firm Reminds Endologix Inc. Investors of Important Deadline in Class Action Filed by Firm - ELGX |
02/14/2017 |
GN
| Endologix Completes Patient Enrollment in the Ovation® LUCY Study |
02/07/2017 |
GN
| Endologix to Report Fourth Quarter and Full Year 2016 Financial Results on February 22, 2017 |
02/03/2017 |
GN
| Endologix to Present at Leerink Partners 6th Annual Global Healthcare Conference |
02/03/2017 |
GN
| SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Endologix Inc. (ELGX) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit |
01/30/2017 |
GN
| ELGX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Endologix, Inc. and a Lead Plaintiff Deadline of March 6, 2017 |
01/27/2017 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endologix, Inc. of Class Action Lawsuit and Upcoming Deadline – ELGX |
10/01/2012 |
GN
| Endologix Appoints Charles Love Vice President of Clinical Affairs |
07/26/2012 |
GN
| Endologix Reports 33% Revenue Growth for the Second Quarter 2012 |
07/20/2012 |
GN
| Endologix to Report Second Quarter 2012 Financial Results and Provide Operational and Product Pipeline Updates on July 26, 2012 |
05/30/2012 |
GN
| Endologix Announces Public Offering of 2.7 Million Shares of Common Stock |
04/26/2012 |
GN
| Endologix Reports 32% Revenue Growth for the First Quarter 2012 |
04/12/2012 |
GN
| Endologix to Report First Quarter 2012 Financial Results on April 26, 2012 |
03/05/2012 |
GN
| Endologix to Present at 24th Annual ROTH Conference |
02/22/2012 |
GN
| Endologix Reports 24% and 22% Revenue Growth for the Full Year and Fourth Quarter 2011 |
02/10/2012 |
GN
| Endologix to Report Fourth Quarter and Full Year 2011 Financial Results on February 22, 2012 |
02/09/2012 |
GN
| Endologix Completes Enrollment in PEVAR Randomized Trial |
01/31/2012 |
GN
| Endologix Announces First Patient Treated in Ventana(TM) U.S. Clinical Trial |
01/03/2012 |
GN
| Endologix to Present at the 30th Annual J.P. Morgan Healthcare Conference |
11/21/2011 |
GN
| Endologix to Present at Three Upcoming Investor Conferences |
11/08/2011 |
GN
| Endologix to Present at Two Upcoming Conferences |
10/27/2011 |
GN
| Endologix Reports 25% Third Quarter 2011 Revenue Growth |
10/18/2011 |
GN
| Endologix to Report Third Quarter 2011 Financial Results on October 27, 2011 |
09/22/2011 |
GN
| Endologix to Present at the Jefferies 2011 Global Healthcare Conference |
09/06/2011 |
GN
| Endologix to Present at Three Upcoming Conferences |
09/06/2011 |
GN
| Endologix Receives IDE Approval for the Ventana(TM) Fenestrated Stent Graft System |
08/30/2011 |
GN
| Endologix Appoints Ruth Lyons Vice President of Global Marketing |
|
|